Jon Read

3.7k citations

40 papers · 2.1k indexed · h-index 25

Molecular Biology top 5%
- Melanoma and MAPK Pathways 4
- Cancer therapeutics and mechanisms 4
- Protein Tyrosine Phosphatases 4
- Biochemical and Molecular Research 3
- Protein Kinase Regulation and GTPase Signaling 3
Toxicology top 5%
Cancer Research top 10%
Computational Theory and Mathematics top 2%
Organic Chemistry top 5%
Cellular and Molecular Neuroscience
- Axon Guidance and Neuronal Signaling 4
Analytical Chemistry
- Chromatography in Natural Products 4
Materials Chemistry
- Enzyme Structure and Function 4

Co-authors: R.L. Brady Richard B. Sessions V.J. Winter R. Tranter David Carling J. Breed Dorin Toader Huawei Chen
Cited by: Molecular Biology Toxicology Cancer Research
Journals: Bioorganic & Medicinal Chemistry Letters (12 papers)Journal of Medicinal Chemistry (6 papers)Biochemical Journal (3 papers)
Partner nations: United Kingdom United States Singapore

In The Last Decade

Jon Read

40 papers receiving 2.0k citations

Peers

Countries citing papers authored by Jon Read

Since Specialization

Citations

This map shows the geographic impact of Jon Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Read more than expected).

Fields of papers citing papers by Jon Read

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Read. The network helps show where Jon Read may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jon Read, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jon Read Line = papers co-authored together Jon Read links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein–Ligand Interactions and High Selectivity Journal of Medicinal Chemistry ·Gavin W. Collie,Matthew Clark,Anthony D. Keefe,Andrew Madin,Jon Read,Innokenty Innokentyevich Grigoryev,Ying Zhang	2024	15
2	AMP-activated protein kinase activation suppresses leptin expression independently of adipogenesis in primary murine adipocytes Biochemical Journal ·Sophia Bustraan,Heleni Kalkandi,Chad Whilding,Betheney R. Pennycook,David M. Smith,Alexis R. Barr,Jon Read,David Carling,Tadaharu Adachi	2024	5
3	Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase Bioorganic & Medicinal Chemistry Letters ·Daniel H. O’Donovan,Mpho Kgomo,Martin J. Packer,Ryan Greenwood,Kurt G. Pike,Sameer Kawatkar,Andrew Bloecher,James Robinson,Jon Read,Erin Code,Jessie Hao-Ru Hsu,Minhui Shen,Ridam Kundu,Peter Barton,Shaun Fillery,Beth Williamson,Philip B. Rawlins,Sharan K. Bagal	2021	11
4	Drug discovery for epigenetics targets Drug Discovery Today ·Geoffrey A. Holdgate,Catherine Bardelle,Elias Foisner,Jon Read,Daniel H. O’Donovan,James M. Smith,Nidhal Selmi,Robert J. Sheppard	2021	22
5	Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors Bioorganic & Medicinal Chemistry Letters ·Bernard Barlaam,Scott Boiko,Scott Boyd,Hannah Dry,Lakshmaiah Gingipalli,Timothy P. Ikeda,Tony Johnson,Sameer Kawatkar,Olivier Lorthioir,Andy Pike,Hannah Pollard,Jon Read,Qibin Su,Haiyun Wang,Huimin Wang,Fulya Çalıkoğlu,Peng Wang,Scott D. Edmondson	2020	3
6	Effect of different γ-subunit isoforms on the regulation of AMPK Biochemical Journal ·Andrés F. Flor-López,Naveenan Navaratnam,Ana Lima,Jon Read,David Carling	2017	49
7	Mapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease Nature Communications ·Constanza Celano,Michał Biśta,Matthew D. Newton,Anne U. Goeppert,Maria Emanuela Cuomo,Euan Gordon,Bahman Javadian,Jon Read,Jonathan D.J. Wrigley,David Rueda,Ben Taylor	2017	54
8	Discovery of cofactor-specific, bactericidal Mycobacterium tuberculosis InhA inhibitors using DNA-encoded library technology Proceedings of the National Academy of Sciences ·Holly H. Soutter,Matthew Clark,John W. Cuozzo,Christoph E. Dumelin,Marie-Aude Guié,Sevan Habeshian,Anthony D. Keefe,A. Feizabadi,Eric A. Sigel,Dawn M. Troast,Ying Zhang,Andrew D. Ferguson,Gareth M. Davies,Andrielle Adelina Teodoro Jesus,J. Breed,Prashanti Madhavapeddi,Jon Read	2016	46
9	Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis Journal of Medicinal Chemistry ·Pravin S. Shirude,Prashanti Madhavapeddi,Maruti Naik,Kannan Murugan,Vikas Shinde,Radha Nandishaiah,Jyothi Bhat,Anupriya Kumar,Shahul Hameed,Geoffrey A. Holdgate,Gareth M. Davies,Helen McMiken,A. I. Bodnya,Anisha Ambady,Janani Venkatraman,Manoranjan Panda,Balachandra Bandodkar,Vasan K. Sambandamurthy,Jon Read	2013	85
10	Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases Bioorganic & Medicinal Chemistry Letters ·Les A. Dakin,M. Block,Huawei Chen,Erin Code,James J. Dowling,Xiaomei Feng,Andrew D. Ferguson,Isabelle Green,Alexander W. Hird,Tina Howard,Erika Krasnickas Keeton,Michelle L. Lamb,Paul D. Lyne,Hannah Pollard,Jon Read,Allan Wu,Tao Zhang,Xiaolan Zheng	2012	85
11	Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol ACS Chemical Biology ·Jiaquan Wu,Francoise Powell,Nicholas Larsen,Zhongwu Lai,Dzhanan Sherif,Jon Read,Rong-Fang Gu,Mark J. Roth,Dorin Toader,Jamal Saeh,Huawei Chen	2012	118
12	Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Vibha Oza,Susan Ashwell,Patrick Brassil,J. Breed,Juliet Ngozi O. Oka,Chun Deng,Michael Grondine,Candice L. Horn,Marine Souto Alves,Paul D. Lyne,Nicholas J. Newcombe,Martin Pass,Jon Read,Mei Su,Dorin Toader,Dingwei Yu,Yan Yu,Sonya Zabludoff	2012	19
13	An analysis of subdomain orientation, conformational change and disorder in relation to crystal packing of aspartic proteinases Acta Crystallographica Section D Biological Crystallography ·David Bailey,Elisabeth P. Carpenter,Alun R. Coker,Nikolai Jul Steensen,Jon Read,Arwyn T. Jones,P.T. Erskine,C. F. Aguilar,M. Badasso,Luca Toldo,Friedrich Rippmann,J. Sanz‐Aparicio,Armando Albert,Tom L. Blundell,N B Roberts,S. P. Wood,J.B. Cooper	2012	5
14	Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines Bioorganic & Medicinal Chemistry Letters ·Catherine Bardelle,Darren A.E. Cross,Sara Davenport,Jason G. Kettle,Eun Jung Ko,Andrew G. Leach,Andrew Mortlock,Jon Read,Nicola Roberts,Peter Robins,Emma Williams	2008	49
15	Structure-based design of protein tyrosine phosphatase-1B inhibitors Bioorganic & Medicinal Chemistry Letters ·Emma Black,J. Breed,Alexander L. Breeze,Kevin J. Embrey,Robert Garcia,Thomas W. Gero,Bismark Kofi Meisuh,Peter W. Kenny,Andrew Morley,Claire A. Minshull,Andrew Pannifer,Jon Read,Amanda Rees,Daniel Russell,Dorin Toader,Julie A. Tucker	2005	60
16	Mapping the binding site for gossypol-like inhibitors of Plasmodium falciparum lactate dehydrogenase Molecular and Biochemical Parasitology ·Rebecca Conners,Christel Brunet,Jon Read,Angus Cameron,Richard B. Sessions,Livia Vivas,Anna Easton,Simon L. Croft,R.L. Brady	2005	56
17	The crystal structure of human phosphoglucose isomerase at 1.6 Å resolution: implications for catalytic mechanism, cytokine activity and haemolytic anaemia Journal of Molecular Biology ·Jon Read,Jake T. M. Pearce,Xiaochun Li,Hilary Muirhead,John M. Chirgwin,Christopher Davies	2001	89
18	Reply Parasitology Today ·Jon Read,Richard B. Sessions,R.L. Brady	2000	1
19	Effector Sites in the Three-Dimensional Structure of Mammalian Sperm β-Acrosin Structure ·R. Tranter,Jon Read,Roy Jones,R.L. Brady	2000	34
20	Purification, co-crystallization and preliminary X-ray analysis of the natural aspartic proteinase inhibitor I^A3 complexed with saccharopepsin fromSaccharomyces cerevisiae Acta Crystallographica Section D Biological Crystallography ·M. Badasso,Jon Read,V. Dhanaraj,J.B. Cooper,S. P. Wood,Tom L. Blundell,Thomas Dreyer,Jakob R. Winther	2000	1

About Jon Read

Jon Read is a scholar working on Molecular Medicine, Molecular Biology and Analytical Chemistry, having authored 40 papers that have together received 2.1k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), Cancer therapeutics and mechanisms (4 papers), Axon Guidance and Neuronal Signaling (4 papers), Chromatography in Natural Products (4 papers), Enzyme Structure and Function (4 papers), Protein Tyrosine Phosphatases (4 papers), Biochemical and Molecular Research (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Molecular Biology (1.3k citations), Toxicology (59 citations) and Cancer Research (236 citations). Jon Read has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include R.L. Brady, Richard B. Sessions, V.J. Winter, R. Tranter, David Carling, J. Breed, Dorin Toader, Huawei Chen, Jason G. Kettle and Catherine Bardelle. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Biochemical Journal, Journal of Molecular Biology and ACS Chemical Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact